参考文献/References:
[1] Padro T,Manfrini O,Bugiardini R,et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ’coronary microvascular dysfunction in cardiovascular disease’[J]. Cardiovasc Res,2020,116(4):741-755.
[2] Taqueti VR,di Carli MF. coronary microvascular disease pathogenic mechanisms and therapeutic options:JACC state-of-the-art review[J]. J Am Coll Cardiol,2018,72(21):2625-2641.
[3] Triantafyllou A,Anyfanti P,Triantafyllou G,et al. Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals[J]. J Am Soc Hypertens,2016,10(8):640-646.
[4] 刘颖,刘颜,王立立,等. 血管内皮细胞功能障碍及修复与高血压关系探讨[J]. 中华老年心血管病杂志,2018,20(7):769-771.
[5] Liang J,Li Y,Chen L,et al. Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension:a substudy of EXCAVATION-CHN1[J]. J Transl Med,2019,17(1):368-379.
[6] Lazzeroni D,Rimoldi O,Camici PG. From left ventricular hypertrophy to dysfunction and failure[J]. Circ J,2016,80(3):555-564.
[7] Sun G,Liu F,Xiu C. High thoracic sympathetic block improves coronary microcirculation disturbance in rats with chronic heart fail ure[J]. Microvasc Res,2019,122:94-100.
[8] Tzortzis S,Ikonomidis I,Triantafyllidi H,et al. Optimal blood pressure control improves left ventricular torsional deformation and vascular function in newly diagnosed hypertensives:a 3-year follow-up study[J]. J Cardiovasc Transl Res,2020,13(5):814-825.
[9] Kachur S,Morera R,de Schutter A,et al. Cardiovascular risk in patients with prehypertension and the metabolic syndrome[J]. Curr Hypertens Rep,2018,20(2):15.
[10] Wasserman DH,Wang TJ,Brown NJ. The vasculature in prediabetes[J]. Circ Res,2018,122(8):1135-1150.
[11] Sezer M,Kocaaga M,Aslanger E,et al. Bimodal pattern of coronary microvascular involvement in diabetes mellitus[J]. J Am Heart Assoc,2016,5(11):e003995.
[12] Banovic M,Brkovic V,Nedeljkovic I,et al. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries[J]. Diab Vasc Dis Res,2016,13(3):220-227.
[13] Wielicka M,Neubauer-Geryk J,Brandt-Varma A,et al. Skin microvascular circulation is not affected by diabetes duration in young patients with non-complicated type 1 diabetes mellitus[J]. Pediatr Endocrinol Diabetes Metab,2019,25(4):183-187.
[14] Singh SS,Roeters-van Lennep JE,Lemmers RFH,et al. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus:a prospective cohort study[J]. Acta Diabetol,2020,57(6):725-732.
[15] Bagi Z,Feher A,Cassuto J. Microvascular responsiveness in obesity:implications for therapeutic intervention[J]. Br J Pharmacol,2012,165(3):544-560.
[16] Bajaj NS,Osborne MT,Gupta A,et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients[J]. J Am Coll Cardiol,2018,72(7):707-717.
[17] Ziegler T,Abdel Rahman F,Jurisch V,et al. Atherosclerosis and the capillary network; pathophysiology and potential therapeutic strategies[J]. Cells,2019,9(1):50.
[18] Campia U,Tesauro M,Cardillo C. Human obesity and endothelium-dependent responsiveness[J]. Br J Pharmacol,2012,165(3):561-573.
[19] Yu S,Kim SR,Jiang K,et al. Quercetin reverses cardiac systolic dysfunction in mice fed with a high-fat diet:role of angiogenesis[J]. Oxid Med Cell Longev,2021,2021(8):1-11.
[20] Wu MD,Moccetti F,Brown E,et al. Lipoprotein apheresis acutely reverses coronary microvascular dysfunction in patients with severe hypercholesterolemia[J]. JACC Cardiovasc Imaging,2019,12(8 Pt 1):1430-1440.
[21] Reindl M,Reinstadler SJ,Feistritzer HJ,et al. Relation of low-density lipoprotein cholesterol with microvascular injury and clinical outcome in revascularized ST-elevation myocardial infarction[J]. J Am Heart Assoc,2017,6(10):e006957.
[22] Toda N,Okamura T. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide:an overview[J]. J Clin Pharmacol,2013,53(12):1228-1239.
[23] Wang YD,Chen WQ,Li Y,et al. Related risk factors of PET/CT detected coronary microvascular disease in patients with chest pain and no obstructive coronary artery disease[J]. Zhonghua Xin Xue Guan Bing Za Zhi,2020,48(11):942-947.
[24] van de Hoef TP,Echavarria-Pinto M,Meuwissen M,et al. Contribution of age-related microvascular dysfunction to abnormal coronary:hemodynamics in patients with ischemic heart disease[J]. JACC Cardiovasc Interv,2020,13(1):20-29.
[25] Ramandika E ,Kurisu S,Nitta K,et al. Effects of aging on coronary flow reserve in patients with no evidence of myocardial perfusion abnormality[J]. Heart Vessels,2020,35(12):1633-1639.
[26] Chen J,Liu X,Qin X,et al. Coronary collateral microcirculation reserve becomes vestigial with aging[J]. Cardiology,2021,146(1):11-18.
[27] Waheed N,Elias-Smale S,Malas W,et al. Sex differences in non-obstructive coronary artery disease[J]. Cardiovasc Res,2020,116(4):829-840.
[28] Dedkov EI,Oak K,Christensen LP,et al. Coronary vessels and cardiac myocytes of middle-aged rats demonstrate regional sex-specific adaptation in response to postmyocardial infarction remodeling[J]. Biol Sex Differ,2014,5(1):1.
[29] Chung JH,Lee KE,Lee JM,et al. Effect of sex difference of coronary microvascular dysfunction on long-term outcomes in deferred lesions[J]. JACC Cardiovasc Interv,2020,13(14):1669-1679.
[30] Miura H,Toyama K,Pratt P,et al. Cigarette smoking impairs Na+-K+-ATPase activity in the human coronary microcirculation[J]. Am J Physiol Heart Circ Physiol,2011,300(1):H109-H117.
[31] Huxley RR. Light smoking confers up to half the amount of the cardiovascular risk associated with smoking a pack of cigarettes a day[J]. BMJ Evid Based Med,2019,24(2):77.
[32] Pywell MJ,Wordsworth M,Kwasnicki RM,et al. The Effect of electronic cigarettes on hand microcirculation[J]. J Hand Surg Am,2018,43(5):432-438.
[33] Mehta PK,Thobani A,Vaccarino V. Coronary artery spasm,coronary reactivity,and their psychological context[J]. Psychosom Med,2019,81(3):233-236.
[34] Vaccarino V,Bremner JD. Behavioral,emotional and neurobiological determinants of coronary heart disease risk in women[J]. Neurosci Biobehav Rev,2017,74(Pt B):297-309.
[35] Vancheri F,Longo G,Vancheri S,et al. Coronary microvascular dysfunction[J]. J Clin Med,2020,9(9):2880.
[36] Koletsos N,Gkaliagkousi E,Lazaridis A,et al. Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors[J]. Rheumatology (Oxford),2021,60(6):2834-2841.
[37] Chen C,Wei J,Albadri A,et al. Coronary microvascular dysfunction- epidemiology,pathogenesis,prognosis,diagnosis,risk factors and therapy[J]. Circ J,2016,81(1):3-11.
[38] Vianello F,Cella G,Osto E,et al. Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera:the missing piece in the puzzle of their increased cardiovascular risk?[J]. Am J Hematol,2015,90(2):109-113.
[39] Kuo AH, Li C, Huber HF, et al. Perinatal maternal undernutrition does not result in offspring capillary rarefaction in the middle-aged male baboon at rest[J]. J Dev Orig Health Dis,2021,12(3):349-353.
[40] 韩冬柏,刘晓宇,李娜,等. 微循环障碍危险因素的研究进展[J]. 医学综述,2020,26(18):3632-3637.
相似文献/References:
[1]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(12):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[2]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(12):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[3]程晓艺,寇秀玲,黄明刚,等.颈动脉斑块与冠状动脉粥样硬化相关性影像学分析[J].心血管病学进展,2019,(6):960.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.030]
CHENG Xiaoyi,KOU Xiuling,HUANG Minggang,et al.Imaging Analysis of Carotid Plaque and Coronary Artery Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(12):960.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.030]
[4]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[5]谭焜月 刘春霞 熊峰.急性心肌梗死后微循环障碍的非药物治疗研究进展[J].心血管病学进展,2019,(8):1104.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.008]
TAN Kunyue,LIU Chunxia,XIONG Feng.Non-drug Treatment of Coronary Microvascular Dysfunction after Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):1104.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.008]
[6]汤月霞 吴宗贵.脂蛋白a用于预测心血管疾病的争议[J].心血管病学进展,2019,(8):1158.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.022]
TANG Yuexia,WU Zonggui.Controversies about the Use of Lipoprotein() in Predicting Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1158.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.022]
[7]孙静美 尹德春 曲秀芬.炎症信号与心房颤动[J].心血管病学进展,2020,(1):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
SUN Jingmei,YIN Dechun,QU Xiufen.Inflammatory Signals Associated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(12):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
[8]秦莉,张艺文,杨晓倩,等.系统性红斑狼疮合并心力衰竭的危险因素及管理[J].心血管病学进展,2020,(3):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.Risk Factors and Management of Heart Failure in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(12):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]
[9]徐风燕 孙飞龙.非瓣膜性心房颤动患者华法林抗凝质量的临床研究[J].心血管病学进展,2020,(8):868.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.021]
XU Fengyan,SUN Longfei.(Department of Cardiology,Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University,Urumqi 831100,Xinjiang,China)[J].Advances in Cardiovascular Diseases,2020,(12):868.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.021]
[10]游钫,陈新云,蒋小晶,等.正常血压高值人群缺血性心血管疾病发生风险的评估分析[J].心血管病学进展,2020,(10):1091.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.022]
YOU Fang,CHEN Xinyun,JIANG Xiaojing,et al.Risk Assessment of Ischemic-Cardiovascular Diseases in People with High-Normal Value of Blood Pressure[J].Advances in Cardiovascular Diseases,2020,(12):1091.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.022]